With proof-of-concept after the COVID-19 pandemic, the mRNA space stands on firmer ground and is now making headlines that prove its value across new diseases. From MHRA’s latest guidance on mRNA personalized cancer vaccines to the world’s first RNA-based CRISPR therapy for Baby KJ, doors are opening to revolutionary therapeutics and gene editing applications.

The 5th mRNA-Based Therapeutics Summit Europe is the ultimate biopharma platform diving into novel mRNA, sa-RNA and circular RNA design to delivery innovations, giving you the latest insights and connections to turn these breakthroughs into action. Enhanced with the brand-new Gene Editing Focus Day to harness mRNA's power through transient editing strategies, and Investor-Led sessions on what makes an mRNA platform fundable in 2026, leave this meeting with tried and tested strategies to de-risk your programs and secure partnerships in today’s competitive landscape.

Join 170+ senior leaders from Moderna, AstraZeneca, CybernaX Bio, Avocet Bio, and others working on R&D, CMC, business development, and regulatory affairs for three days of learning, networking, and collaboration to put you at the forefront of mRNA and gene editing innovation in 2026.